Related Experiment Video
Updated: Aug 20, 2026

Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Hypertrichosis of the eyelashes caused by bimatoprost
Antonella Tosti1, Massimiliano Pazzaglia, Stylianos Voudouris
1Department of Dermatology, University of Bologna, Italy. tosti@med.unibo.it
Abstract:
The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Accessory Structures of the Eye
Microbiome of the Eye
Ophthalmic Drug Delivery Systems
Angle Closure Glaucoma: Treatment
